OurCrowd (Investment in Cyto) L.P. — Form D
OurCrowd (Investment in Cyto) L.P. of JERUSALEM, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-12-27. The offering totals $500K, of which $17K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-12-27
- Form: D
- Accession: 0001819632-23-000002
- Industry: Pooled Investment Fund
- Exemptions: 06c
- Total offering: $500K
- Amount sold: $17K
- Remaining: $483K
- Minimum investment: $10K
- Investors: 186
- Date of first sale: 2023-12-21
- Security types: fund interests
- Revenue range: No Revenues
- SEC file number: 021-500773
Issuer
- Name: OurCrowd (Investment in Cyto) L.P.
- CIK: 0001819632
- Entity type: Limited Partnership
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2019
- Address: DERECH HEBRON 28, JERUSALEM, L3, 9108001
- Phone: 00972-636-9300
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Andrew Kaye | Director | Jerusalem, L3 |
| Jonathan Medved | Director | Jerusalem, L3 |
| Caleb Chill | Executive Officer | Jerusalem, L3 |
| Robert Citron | Executive Officer | Jerusalem, L3 |
| Andrew Kaye | Executive Officer | Jerusalem, L3 |
| Jonathan Medved | Executive Officer | Jerusalem, L3 |
Other filings by this issuer (3)
More